Correction: Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
J Exp Clin Cancer Res. 2024 Apr 16;43(1):113.
doi: 10.1186/s13046-024-03033-8.
1 State Key Laboratory for Medical Genomics, Collaborative Innovation Center of Hematology, Shanghai Institute of HematologyNational Research Center for Translational Medicine Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
2 Department of Gynecologic Oncology, National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, Chinses Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
3 InxMed (Shanghai) Co., Ltd, Beijing, China.
4 Department of Pathology, Yantai Afliated Hospital of Binzhou Medical University, Yantai, Shandong, China.
5 Laboratory of Obstetrics and Gynecology, Afliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
6 Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. jid09@fudan.edu.cn.
7 Department of Gynecologic Oncology, National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, Chinses Academy of Medical Sciences and Peking Union Medical College, Beijing, China. wulingying@csco.org.cn.
8 State Key Laboratory for Medical Genomics, Collaborative Innovation Center of Hematology, Shanghai Institute of HematologyNational Research Center for Translational Medicine Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. rbren@sjtu.edu.cn.
9 International Center for Aging and Cancer, Hainan Medical University, Hainan Province, Haikou, China. rbren@sjtu.edu.cn.